INTERVIEW: Carmat stays on the beat with potential 2016 artificial heart CE mark

Carmat has taken another step towards approval of its biocompatible artificial heart after developing a portable console that has allowed one patient implanted with the system to return home.

More from Archive

More from Medtech Insight